Control of plasma aldosterone concentration during hemodialysis
Read, V.H.; McCaa, C.S.; Bower, J.D.; McCaa, R.E.
Proceedings of the Clinical Dialysis and Transplant Forum 2: 93-99
1972
ISSN/ISBN: 0094-6044 PMID: 4619676 Document Number: 50016
Document emailed within 1 workday
Related Documents
Matsui, G. 1979: Change of plasma aldosterone concentration before and after hemodialysis Nihon Jinzo Gakkai Shi 21(6): 601-608Studer, A.; Záruba, K.; Grimm, J.; Kuhlmann, U.; Siegenthaler, W.; Vetter, W. 1980: Control of plasma aldosterone during chronic hemodialysis Clinical Nephrology 13(4): 172-176
Pratt, J.H.; Luft, F.C. 1979: The effect of extremely high sodium intake on plasma renin activity, plasma aldosterone concentration, and urinary excretion of aldosterone metabolites Journal of Laboratory and Clinical Medicine 93(5): 724-729
Men'shikov, V.V.; Kukes, V.G.; Gneushev, E.T.; Rubin, M.P. 1970: Determination of the secretory rate and concentration of aldosterone in blood plasma by means of 1,2-alpha-aldosterone-H3 Laboratornoe Delo 9: 547-551
Vetter, W.; Zaruba, K.; Armbruster, H.; Beckerhoff, R.; Strebel, U.; Siegenthaler, W. 1973: Plasma aldosterone and plasma renin activity during hemodialysis Verhandlungen der Deutschen Gesellschaft für Innere Medizin 79: 763-767
Hsieh, B.S.; Chen, F.W.; Chen, W.Y.; Yen, T.S.; Hsu, H.C.; Hsieh, Y.F. 1980: Primary aldosteronism. IV. Observations on the postural variation of plasma aldosterone concentration Journal of the Formosan Medical Association 79(5): 454-459
Maegaki, Y.; Kimura, M.; Yoshino, K. 1992: Plasma renin activity and serum aldosterone concentration in severe handicapped patients No to Hattatsu 24(1): 32-36
Pinsker, P.; Bultasová, H.; Hrńová, Z.; Dráb, K.; Zofková, I.; Veselková, A. 1977: Secretion, plasma concentration and kinetics of aldosterone in patients with stenosis of the renal artery Review of Czechoslovak Medicine 23(4): 214-227
Knowlen, G.G.; Kittleson, M.D.; Nachreiner, R.F.; Eyster, G.E. 1983: Comparison of plasma aldosterone concentration among clinical status groups of dogs with chronic heart failure Journal of the American Veterinary Medical Association 183(9): 991-996
Alquist, M.; Thysell, H.; Ungerstedt, U.; Hegbrant, J. 1999: Development of a urea concentration gradient between muscle interstitium and plasma during hemodialysis International Journal of Artificial Organs 22(12): 811-815
Martínez, M.E.; Miguel, J.L.; Gómez, P.; Selgas, R.; Salinas, M.; Gentil, M.; Mateos, F.; Montero, J.L.; Sánchez Sicilia, L. 1983: Plasma calcitonin concentration in patients treated with chronic dialysis: differences between hemodialysis and CAPD Clinical Nephrology 19(5): 250-253
Frisina, N.; Costa, G.; Buemi, M.; Lasco, A. 1978: Aldosterone and prolactin secretion. I. Effects of sulpiride on plasma aldosterone levels in normal subjects Bollettino della Societa Italiana di Biologia Sperimentale 54(23): 2473-2476
Reinberg, A.; Dupont, W.; Touitou, Y.; Lagoguey, M.; Bourgeois, P.; Touitou, C.; Muriaux, G.; Przyrowsky, D.; Guillemant, S.; Guillemant, J.; Brière, L.; Zeau, B. 1981: Clinical chronopharmacology of ACTH 1-17. II. Effects on plasma testosterone, plasma aldosterone, plasma and urinary electrolytes (K, Na, Ca and Mg) Chronobiologia 8(1): 11-31
Ley, S.J.; Waterman, A.E.; Livingston, A. 1993: Plasma free fatty acid concentration in control and lame sheep Veterinary Record 133(18): 450
Vetter, H.; Zumkley, H.; Glänzer, K.; Witassek, F.; Wollnik, S.; Vetter, W. 1980: Renin-angiotensin-aldosterone system in essential hypertension. Inappropriately high plasma aldosterone in young patients with severe hypertension and in older hypertensives Schweizerische Medizinische Wochenschrift 110(50): 1938-1941
Auer, I.O.; Münch, L.; Schmid, L. 1976: The value of the concentration of carcinoembryonal antigen (CEA) in the plasma in first diagnoses and course control of treated gastrointestinal neoplasms Verhandlungen der Deutschen Gesellschaft für Innere Medizin 82 Pt 1: 1016-1020
Ocón, J.; Piña, C.; Castellet, R.; Vila, R.; del Río, G.; Arnau, C. 1985: Clinical evaluation of penbutolol (Hoe 893d) (beta adrenergic blocker), alone and in combination with hydrochlorothiazide, in the treatment of arterial hypertension. II. Effect on plasma electrolytes, renal function, plasma renin and aldosterone activity and risk factors, including plasma lipids Medicina Clinica 85(2): 53-57
Klumpp, F.; Klaus, D. 1978: Effect of oral contraceptives on the capacity to stimulate plasma renin activity and plasma aldosterone Die Medizinische Welt 29(6): 228-231
Wernze, H.; Hilfenhaus, M.; Rietbrock, I.; Schüttke, R.; Kühn, K. 1975: Plasma renin activity and plasma aldosterone during anaesthesia and operative stress and beta-adrenergic blockade Der Anaesthesist 24(11): 471-476
Hory, B.; Henriet, M.T. 1983: Variations in blood aldosterone, plasma renin activity and plasma levels of converting enzyme during bicarbonate dialysis in chronic kidney failure Nephrologie 4(4-5): 229-230